Calculate your HOMA-IR from fasting glucose and fasting insulin — the metabolic number your doctor probably isn't checking.
HOMA-IR stands for Homeostatic Model Assessment of Insulin Resistance. It's a calculation, not a direct lab test. You take two numbers — fasting glucose and fasting insulin — and plug them into a formula: (glucose × insulin) ÷ 405. The result tells you something that neither number reveals on its own: how hard your pancreas is working to keep your blood sugar in range.
Here's why that matters. Fasting glucose is what your doctor checks every year. It's on every basic metabolic panel. And it's the last domino to fall in metabolic disease. Your body will do extraordinary things — flooding your bloodstream with insulin, burning out beta cells — to keep that glucose number looking "normal." By the time your fasting glucose actually goes above 100 mg/dL, the metabolic dysfunction has been running for 5 to 10 years.
Fasting insulin is the early warning signal. It goes up years before glucose moves. But here's the problem: it's not on the standard panel. Most doctors don't order it. Most patients have never had one drawn.
HOMA-IR combines both numbers to give you the clearest accessible picture of insulin sensitivity — or the lack of it. It's the metabolic metric that catches what glucose alone misses.
This isn't a knock on your doctor. It's a systems problem. The standard metabolic panel includes fasting glucose and sometimes HbA1c. That's what insurance reimburses, that's what the EMR flags, and that's what gets checked at your annual physical. Fasting insulin isn't part of the protocol.
The conventional approach to metabolic disease works like this: wait for glucose to cross 100 (impaired fasting glucose), then 126 (diabetes). Once it crosses the line, you get the diagnosis. The problem is that the line is drawn at the point where the disease is already established — not where it starts.
A fasting insulin test costs about $12 at Quest Diagnostics. Twelve dollars. It's the most cost-effective early warning system for metabolic disease that exists in clinical medicine, and it's almost never ordered because it's not on the checkbox. That's not malice. It's inertia. But the result is the same: millions of people walking around with "normal" glucose and undetected insulin resistance.
This is the pattern that shows up in clinical practice every single week. A patient comes in with vague but real complaints — gaining weight despite eating well, energy crashes in the afternoon, waking up at 3 a.m., brain fog that won't lift. Their annual physical says everything is fine. Glucose: 94. A1c: 5.4. Doctor says keep doing what you're doing.
But nobody ordered a fasting insulin. When you do, it comes back at 18 or 22 or sometimes higher. The pancreas is screaming to keep that glucose in range.
This person's glucose is textbook "normal." Their doctor would see 95 and move on. But a HOMA-IR of 4.2 is clear insulin resistance. Their body is producing 4–5 times the insulin it should need to manage a normal glucose load. That compensation masks the problem until the pancreas can't keep up anymore — and then glucose finally rises, the A1c finally crosses 5.7, and now it's "pre-diabetes."
The diagnosis arrives 5–10 years after the disease started. During those years, hyperinsulinemia — chronically elevated insulin — is driving inflammation, promoting visceral fat storage, disrupting hormone signaling, and accelerating vascular damage. All while the chart says "metabolically healthy."
The math is straightforward:
Both values must be fasting — meaning at least 8–12 hours without food. Non-fasting numbers will give you an unreliable result. If your lab report says "glucose" without specifying fasting, check with your provider.
The model was originally published by Matthews et al. in 1985 and has been validated across dozens of studies against the gold standard euglycemic clamp. It's not perfect — no single calculation is — but for a number you can get from a $15 blood draw, it's remarkably informative.
This calculator uses mg/dL for glucose and µIU/mL for insulin, which is standard for U.S. labs. If your glucose is in mmol/L (common outside the U.S.), multiply by 18.016 to convert. If your insulin is in pmol/L, divide by 6.945 to convert to µIU/mL.
First: don't panic, and don't self-diagnose. A single number is a data point, not a verdict. That said, an elevated HOMA-IR is a signal worth acting on — early. Here's what the research and clinical experience point to:
Insulin resistance doesn't happen alone. It's connected to nearly every major chronic disease risk factor: cardiovascular disease, non-alcoholic fatty liver disease, PCOS, certain cancers, and neurodegenerative conditions. Elevated insulin drives inflammation. It promotes fat storage — particularly visceral fat. It disrupts sex hormones. It's not just a "diabetes thing." It's a metabolic foundation issue.
That's why catching it early — at the HOMA-IR stage, not the "your A1c just hit 6.5" stage — changes the entire trajectory. At a HOMA-IR of 2.5, the condition is reversible with aggressive lifestyle change. At an A1c of 7.0, you're managing a disease. The gap between those two points is measured in years and organ damage.
A single fasting insulin test. Twelve dollars. A calculation you can do in your head. That's the difference between catching metabolic dysfunction a decade early and waiting for a diagnosis you could have avoided.
About this calculator: Built by the clinical team behind Lab Sage. The HOMA-IR formula and interpretation ranges used here are based on published medical literature and clinical experience. This tool is for educational purposes and does not constitute medical advice. Always discuss your lab results with a qualified healthcare provider.
Lab Sage analyzes your full panel with functional medicine ranges — the tighter ranges that catch problems while they're still reversible. Ratios, patterns, cross-marker connections. Not just flags.
Analyze Your Full Lab Panel →